What Clinicians Should Know About Surrogate Endpoints in Hematologic Malignancies
Use of surrogates as primary endpoints is commonplace in hematology/oncology clinical trials. As opposed to prognostic markers, surrogates are endpoints th
Use of surrogates as primary endpoints is commonplace in hematology/oncology clinical trials. As opposed to prognostic markers, surrogates are endpoints th
A joint International Society of Oral Oncology-Multinational Association for Supportive Care in Cancer and ASCO guideline seeks to fill a gap in the clinical guidance…
Palliative care facilitates communication and helps with symptom management, the researchers noted.
In those who did not undergo EV treatment, NECTIN4 amplifications were not connected with outcomes.
A 23-year-old man presented with leukopenia and thrombocytopenia persisting for four years. He complained of occasional epistaxis and easy bruising every f
AbstractBackgroundIncomplete treatment of congestion often leads to worsening heart failure (HF). The remote dielectric sensing (ReDS) system is an electromagnetic energy–based technology that accu…
SERVIR is a NASA and USAID partnership that supports locally led efforts to strengthen climate resilience, food and water security, forest and carbon management, and…
AbstractBackgroundAnthracycline-induced cardiotoxicity (AIC) debilitates quality of life in cancer survivors. Serial characterizations are lacking of the molecular processes occurring with AIC.Obje…
A roundtable discussion, moderated by Thomas Martin, MD, of the UCSF Helen Diller Family Comprehensive Cancer Center, focused on CAR T-cell therapy considerations in the…
My esteemed guest on this Healthcare unfiltered podcast is Dr. Manmeet Ahluwalia, Deputy Director, Chief Scientific Officer, and Chief of Solid Tumor Medical…